Abstract:Endometriosis is an estrogen-dependent gynecologic disease, which is characterized by the elevated ratio of ERβ/ERα expression. Retrograde menstruation leads to ectopic erythrocytes deposition and iron overload at pelvic cavity in endometriosis. Lipocalin 2 (LCN2) is a secretory protein that plays important role during iron transport and metabolism. To date, the relationship of estrogen and iron homeostasis is not well studied yet. The aim of our study was to investigate the role of estrogen in regulating iron metabolism in endometriosis. Sixty-eight women with endometriosis and forty-three women without endometriosis (controls) were included, and their serum levels of estrodiol and LCN2 were determined for via ELISA. Primary cultures of ESCs were obtained in vitro. The expression of estrogen receptor (ER) α, ERβ, and LCN2 was examined by qPCR, western blot, and ELISA. ChIP was used to investigate how ER regulated LCN2. Cell viability was assessed by Cell Counting Kit-8 assay. Reactive oxygen species production was evaluated by dihydroethidium staining. In addition, the intracellular ferrous iron level (Fe2+ ) were examined using an iron assay kit. Ferroptosis was evaluated by Cyclooxygenase-2(COX-2), Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4), glutathione peroxidase 4 (GPX4) and ferritin heavy chain 1(FTH1). Elevated serum LCN2 levels were found in women with endometriosis compared to those without. A positive correlation of E2 and LCN2 was observed in endometriosis group but not in controls. E2 dose-dependently increased the LCN2 expression in ESCs. This was also seen in the presence of ERα antagonist alone but not with ERβ antagonist alone. Interestingly, ERα bind to LCN2 promoter and attenuated the expression of LCN2. Moreover, E2-induced LCN2 expression resulted increased intracellular iron concentrations. Importantly, LCN2 attenuated GPX4 and FTH1 expression, increased COX-2 and ACSL4 levels, which in turn inhibited the ferroptosis of ESCs. This ferroptosis inhibition effect can also be partly reversed by the inhibition of ERβ or overexpression of ERα. Our studies demonstrate that upregulated E2 may inhibit ferroptosis via ERβ/ERα/ LCN2 pathway, potentially resulted in endometriotic tissue survival and progression, ERβ/ERα/LCN pathway may be a potential target for endometriosis treatment.

The effect of estrogen on the transcription of focal-adhesion kinase in endometrial carcinoma cells

Abstract #1504468: Estrogen Attenuates Ferroptosis Via Estrogen Receptor (ER) Β/erα/lipocalin 2 Pathway in Endometriosis

Role of Mast Cells in Estrogen-Mediated Experimental Endometriosis in Rats

CTHRC1 Overexpression Promotes Ectopic Endometrial Stromal Cell Proliferation, Migration and Invasion Via Activation of the Wnt/β-catenin Pathway

Alteration of Focal Adhesion Kinase Expression in Eutopic Endometrium of Women with Endometriosis

Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα)

Nongenomic effect of estrogen on the MAPK signaling pathway and calcium influx in endometrial carcinoma cells.

Effect of Estrogen and Progesterone on the Expression of RCAS1 in Breast Cancer Cell Line MCF-7

Serum Estradiol Levels in Controlled Ovarian Stimulation Directly Affect the Endometrium.

Focal Adhesion Kinase Expression in Ovarian Endometriosis

Focal adhesion kinase overexpression in endometrial neoplasia

[Analysis Different Transcriptional Factors in Different Phenotype Endometrial Cancer Cells].

Expression of focal adhesion kinase in patients with endometrial cancer: a clinicopathologic study

Function of Estrogen Receptor Isoforms Α and Β in Endometrial Carcinoma Cells

Study on the regulatory effect of estrogen receptor α on the invasion of endometrial carcinoma

The Role of 17 beta-Estrogen in Escherichia coli Adhesion on Human Vaginal Epithelial Cells via FAK Phosphorylation

Expression and clinical significance of FAK and Src proteins in human endometrial adenocarcinoma

Impact of estradiol in inducing endometrial cancer using RL95-2

[Effects of ICI182780 (faslodex) on Proliferation and Apoptosis Induced by 17Beta-Estradiol in Endometrial Carcinoma Cells].

C-Fos-regulated Matrix Metalloproteinase-9 Expression is Involved in 17Β-Estradiol-promoted Invasion of Human Endometrial Stromal Cell

17SS-Estradiol-induced Human Endometrial Stromal Cell Invasion is Dependent on C-Fos-mediated Matrix Metalloproteinase-9 Expression